What is Indegene?
Founded in 1998 and headquartered in Bangalore, India, Indegene operates with a model that integrates deep industry expertise with fit-for-purpose technology. The company specializes in providing agile and scalable solutions within the healthcare ecosystem. Its strategic approach combines technological prowess with a nuanced understanding of the healthcare landscape, positioning it as a key player in digital health transformation.
How much funding has Indegene raised?
Indegene has raised a total of $200M across 1 funding round:
Stock Offering
$200M
Stock Issuance/Offering (2021): $200M with participation from Brighton Park Capital and The Carlyle Group
Key Investors in Indegene
Brighton Park Capital
Brighton Park Capital is an investment firm that likely focuses on providing growth capital to companies within the technology and healthcare sectors, leveraging its expertise to drive strategic expansion.
The Carlyle Group
The Carlyle Group is a global investment firm with a broad mandate across private equity, venture and growth capital, real estate, and leveraged finance, known for its extensive international presence and diverse sector investments.
Undisclosed investor
An undisclosed investor participated in this significant funding round, contributing to Indegene's strategic growth initiatives.
What's next for Indegene?
The substantial enterprise-level backing indicates Indegene is likely in a scaling phase, poised for significant market penetration and product development. The recent strategic investment suggests a focus on expanding its technological capabilities and market reach, potentially through acquisitions or enhanced R&D. This capital will likely enable Indegene to further solidify its competitive advantage and explore new avenues for growth within the global healthcare technology market.
See full Indegene company page
